HOME >> MEDICINE >> NEWS
Partnership between NIAID and Sequella yields promising new TB drug for clinical testing

The need for new drugs against tuberculosis (TB) has never been more urgent, as the global burden of the disease continues to grow, and the incidence of extensive drug-resistant (XDR) TB, a virtually untreatable disease, continues to rise. A key component in advancing new health care interventions for TB is the creation of productive partnerships between pharmaceutical companies and the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health.

The success of one such public-private partnership has been demonstrated by Sequella, Inc., which recently received clearance from the Food and Drug Administration to enter Phase I clinical trials with their TB drug candidate SQ109.

SQ109 was discovered in NIAID's intramural laboratories in 1999, and developed with extensive support from NIAID as well as the National Cancer Institute/NIAID Inter-Institute Program for the Development of AIDS-related Therapeutics. (For the history of SQ109 development with NIAID funding, see "Kitchen Sink" at www.niaid.nih.gov/news/focuson/tb/research/treating/default.htm).

These efforts are part of a wide array of NIAID-supported TB research projects, from fundamental research to understand Mycobacterium tuberculosis, the organism that causes TB, through product-oriented translational and clinical studies of potential methods of TB prevention and treatment. The successful transition of SQ109 from the laboratory to clinical testing not only represents a major milestone for the NIAID TB program and Sequella, but also speaks to the successes public-private partnerships can yield.


'"/>

Contact: NIAID News Office
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
12-Sep-2006


Page: 1

Related medicine news :

1. Health Partnership Act endorsed By American College of Physicians
2. Comparison of obstetric outcomes between on-call and patients own obstetricians
3. Explaining a link between strokes and Alzheimers
4. Researchers call for investigation into links between khat use and psychiatric disorders
5. Comparison of patients access to new and better cancer drugs reveals inequalities between countries
6. No link found between autism and celiac disease
7. Research demonstrates link between domestic violence and asthma
8. Correlation between bile duct obstruction and ductal cancer found
9. Health gap between social groups widens in later life
10. Molecular differences between early and advanced melanomas could provide new drug targets
11. Queens studies find new links between wine, fermented foods and cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2018)... ... 20, 2018 , ... A July 12 article in Glamour offers examples of six ... who obtained a weight loss surgery after she was moved to take more control of ... and a half years, she lost close to 90 pounds following her sleeve gastrectomy. “Bariatric ...
(Date:7/22/2018)... (PRWEB) , ... July 20, 2018 , ... Dr. Joseph ... groundbreaking medical devices for cardiology patients after retiring and resigning as a part-time adjunct ... , “I have enjoyed serving on the Johns Hopkins faculty for many ...
(Date:7/22/2018)... ... ... Novant Health is pleased to announce that Chad Setliff will be the new ... Setliff, who begins in the new role on Aug. 12, most recently served as ... Health Clemmons Medical Center. Before that, he was president and COO of Novant Health ...
(Date:7/22/2018)... ANGELES (PRWEB) , ... July 20, 2018 , ... Cosmetic Town, a Los Angeles based ... easier for patients. The website is starting the publication of a series of lists that ... , According to the senior editor of Cosmetic Town , “San Diego is often ...
(Date:7/22/2018)... ... July 21, 2018 , ... "Business Matrix" is a ... Now, in an upcoming episode, the program will focus on sports injury prevention. , ... healthy lifestyle, as well as to have fun or compete professionally. Unfortunately, all sports ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... , Oct. 10, 2017   West Pharmaceutical Services, ... solutions for injectable drug administration, today shared the results ... Adapter for improving the intradermal administration of polio vaccines. ... Vaccination Summit in May 2017 by Dr. Ondrej ... Department, World Health Organization (WHO), and recently published in ...
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
(Date:10/2/2017)... 2017 The Rebound mobile app is poised to ... the tide of prescription drug addiction. The app empowers users ... and stepping down their dosage in a safe, controlled manner ... 2017; the first 100,000 people to sign up will enjoy ... ...
Breaking Medicine Technology:
Cached News: